title: Evaluation of bone metabolism in children with acute lymphoblastic leukemia. A 2-year study from Northern Greece.
authors.forename: Athanasios
authors.initials: A
authors.lastname: Tragiannidis
authors.forename: Fani
authors.initials: F
authors.lastname: Athanassiadou
authors.forename: Israel
authors.initials: I
authors.lastname: Rousso
authors.forename: Michael
authors.initials: M
authors.lastname: Karamouzis
authors.forename: Georgios
authors.initials: G
authors.lastname: Katzos
authors.forename: Ioannis
authors.initials: I
authors.lastname: Tsitouridis
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Sidi
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Koliouskas
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001842:Bone and Bones / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D024042:Collagen Type I / Q000378:metabolism; D005260:Female; D006115:Greece; D006801:Humans; D008297:Male; D010455:Peptides / Q000378:metabolism; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide